LENZ — Lenz Therapeutics Income Statement
0.000.00%
Last trade - 00:00- $303.20m
- $10.85m
- $19.09m
Annual income statement for Lenz Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0 | 0 | 0 | 0 | 19.1 |
| Cost of Revenue | |||||
| Gross Profit | — | — | — | — | 18.7 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 60.4 | 106 | 135 | 58.6 | 110 |
| Operating Profit | -60.4 | -106 | -135 | -58.6 | -91.1 |
| Total Net Non Operating Interest Income / Expense | |||||
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -70.8 | -101 | -125 | -49.8 | -81.6 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -70.8 | -101 | -125 | -49.8 | -82.1 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -70.8 | -101 | -125 | -49.8 | -82.1 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -70.8 | -101 | -125 | -49.8 | -82.1 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -17.1 | -12.9 | -7.67 | -2.34 | -2.85 |
| Special Dividends per Share |